• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Freudenberg Medical Adds Silicone Extrusion Capabilities in Massachusetts

    Positive Long-Term Prospects for Japanese Diabetes Care Market

    Digital X-Ray is as Effective as Lung Ventilation Perfusion in Detecting CTEPH

    CIBC Innovation Banking Provides $25M in Debt Financing to Podimetrics

    Invacare's Interim CEO Permanently Secures Job
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Deducing the Dual Reality of Elizabeth Holmes

    The Return of the AdvaMed MedTech Conference…Live!

    Material Matters: New Materials Call for New Thinking

    5 Ways to Maintain a Talent-Centric Mindset, Even During Economic Uncertainty

    The Changing Face of UK Medical Device Regulations: Most Recent Update
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Providence Enterprise USA Inc.

    Forefront Medical Technology

    JBC Technologies

    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Onshoring Medical Device Manufacturing Can Strengthen Supply Chains

    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Providence Enterprise USA Inc.

    Forefront Medical Technology

    JBC Technologies

    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Single-Use Device Reprocessing Tailwinds and Headwinds

    An examination of the factors impacting growth, or lack thereof, of reprocessing in the current healthcare environment.

    Single-Use Device Reprocessing Tailwinds and Headwinds
    Related Content
    • MEDICAL & BIOTECH MANUFACTURING
    • Breakthrough Device Designation Granted for New Neuromodulation Platform
    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    • Accu-Tube Appoints Matthew Haddle as CEO
    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    Lars Thording, VP—Marketing & Public Affairs, Innovative Health04.17.18
    Many experts predict that the global medical device reprocessing market will grow at a compound annual growth rate (CAGR) of 14.9 percent from 2017 to 2024. This is significant for two reasons. First, such massive growth in reprocessing corresponds (almost 1:1) with increased savings for hospitals and surgery centers. Reprocessors typically charge about 50 percent of each device’s original price; if the reprocessor’s revenue increases by 20 percent, the hospital is saving an equal amount. Second, reprocessing growth means more devices are re-used, and every time a single-use device (SUD) is re-used, the original manufacturer loses the sale of a device. The predicted level of growth in reprocessing cannot be ignored by the original manufacturer, and they have, indeed, launched a strategic and technological defense campaign to contain the growth of the reprocessing market.
     
    But, before we go there, let us take a closer look at the “tailwinds” for reprocessing—the reasons why such large growth is anticipated. Foundationally, over the past 15 to 20 years, reprocessing has evolved through FDA regulation and industry knowledge from a shady, hospital-based activity that arguably put patient safety at risk to a highly professionalized activity, openly pursued by hospitals. Hospitals have discovered the substantial level of savings driven by reprocessing can become a key supply chain strategy that uniquely reduces costs without sacrificing quality. This seemingly impossible goal is achieved when reprocessors can demonstrate substantial equivalence to original devices, and have this sanctioned by FDA clearances.
     
    But that’s not all. A perfect storm is brewing for the industry from the confluence of several tailwinds: increasing cost pressure on hospitals, increasing awareness of environmental waste from SUDs, and rapid procedure growth in exactly the service lines where reprocessing has the biggest financial impact. The cardiology reprocessing market is expected to grow rapidly—specifically electrophysiology (EP) mapping and ablation (A-Fib and similar) procedures are expected to double between 2015 and 2024 and the device market value will grow by even more.
     
    As a result, the tailwinds are blowing strong (especially cardiology reprocessing) and the prospect for hospitals and EP Labs seems rosy. With this confluence of tailwinds, why wouldn’t cardiology reprocessing grow at the rapid pace predicted by experts? In fact, it won’t grow this fast unless the hospital sector and the reprocessing industry answers some key challenges.
     
    Understanding the Barriers to Reprocessing Growth
    Before we get into a detailed explanation of these issues, it helps to first understand the fundamentals of reprocessing. It begins of course when the original manufacturer develops a new device, gets FDA clearance to market it and start selling it to hospitals. Hospitals may then ask reprocessors to target a specific device due to its high cost. In response, reprocessors reverse engineer the device, determine how it can be cleaned and re-used, and get FDA clearance to sell the device again (sometimes three to four, or even more times).
     
    So far, so good. But when original manufacturers—especially in high growth areas like EP—discover the “bleeding” in the form of lost revenue, they respond by inventing new technology and obsoleting the original device. The new device cannot be reprocessed right away, so the hospital purchasing this new device loses savings. This means constantly seeking new FDA clearances is critical for reprocessing savings. If the reprocessor does not achieve new clearances, savings gradually go down due to device lifecycles and planned obsolescence.
     
    Investments in Research and Development Must Drive New FDA Clearances
    And herein lies the subsequent problem: The largest reprocessors in the country have all but stopped getting new FDA clearances to sell reprocessed cardiology and EP devices. In fact, the two largest reprocessors—SterilMed (owned by Johnson & Johnson) and Stryker (previously Ascent)—have achieved only a total of four cardiology clearances since 2012 in a technology market where device lifecycles are arguably shorter than anywhere else. Certainly, some newer reprocessors are breaking records in getting new clearances, but the legacy players are not taking the regulatory steps to enable the predicted growth. Reprocessing won’t grow by 14.9 percent without new clearances. In fact, it won’t grow at all.
     
    The original device manufacturers are creating headwinds as well. The prospect of a 14.9 percent CAGR for an industry where growth is equal to the manufacturers’ losses obviously produces a strong and deliberate response. Manufacturers have always tried to curb the growth of reprocessing, however, there has never been more at stake than in the current debacle over cardiac/EP technology.
     
    Shutting Down Restrictive Technology Innovations
    In addition to speeding up the launch of new technologies, some original manufacturers effectively engage in restrictive technology innovation to prevent EP SUDs from being reprocessed. If “restrictive technology innovation” sounds like an oxymoron, it is because we all assume that technology innovation (like a new and improved diagnostic ultrasound catheter) has a net “good” effect, so how can it be “restrictive”? Technology innovation is restrictive when the incremental clinical or technical improvement is offset by financial consequences that reduce global clinical or technical value.
     
    For example, consider a diagnostic ultrasound catheter with a small clinical improvement that is also specifically designed with increased complexity, choice of material, or computer chips (that shut down the functionality of the device because it has been used before) to NOT be reprocessable. This catheter provides incremental technical improvement when used, however, at the same time, due to the higher cost of the new device plus the cost of not being able to reprocess it, reduces the hospital’s ability to provide overall quality care.
     
    Restrictive technology innovation is already costing EP Labs across the country dearly, and recent new product launches have shown a more consistent commitment to restrict reprocessing. Simply put, the predicted growth in reprocessing is not going to happen until hospitals refuse to purchase devices designed with the primary goal of inhibiting reprocessing. If the reprocessing industry delivers on their responsibility to get new clearances and hospitals cease adopting these restrictive technologies, reprocessing definitely has the potential predicted.
     
    Empowering Hospitals to Make Informed Purchasing Decisions
    Given these issues, many hospitals may begin to decline the adoption of “new-and-improved” technology unless presented with evidence of significant clinical improvement. This in turn will be weighed against the total device cost and loss of reprocessing savings. The hospital’s responsibility is to provide quality care, NOT to adopt new technologies in a fragmented manner that leaves patient care worse off overall because the hospital’s financial solidity is impacted. To that end, device manufacturers should be prepared to promote greater transparency and work with hospitals consultatively, looking at the big picture of overall device spend, quality of care, and reprocessing savings.
     
    There are device manufacturers that do not engage in restrictive technology innovation practices. Hospitals would benefit from aligning themselves with these organizations, so they get to own and control device utilization.
     
    At the same time, for these forward-thinking device manufacturers, this is a great opportunity to become a participant in the projected reprocessing growth—to become part of the tailwind. The medical device manufacturer that incorporates considerations for reprocessability in device design and encourages the optimization of device utilization by supporting reprocessing will be able to grab market share and shorten new product adoption time.
     
    Through these types of partnerships, the entire healthcare industry will make progress toward goals of improving quality of care and reducing overall costs, driving benefit not just to hospitals but also to the patients they serve and the device manufacturers that drive new technology solutions in healthcare.
     
    Related Searches
    • 2015
    • medical
    • regulatory
    • medical device
    Related Knowledge Center
    • Surgical
    Suggested For You
    MEDICAL & BIOTECH MANUFACTURING MEDICAL & BIOTECH MANUFACTURING
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021 MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021
    Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products
    CE Mark Granted to Predictive Software for Kidney Allograft Survival CE Mark Granted to Predictive Software for Kidney Allograft Survival
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    OmniVision Debuts Industry’s First 8 Megapixel Medical-Grade Image Sensors OmniVision Debuts Industry’s First 8 Megapixel Medical-Grade Image Sensors
    Precision Coating Merges with N2 Biomedical Precision Coating Merges with N2 Biomedical
    Babson Diagnostics Raises $31 Million in Series B Funding Babson Diagnostics Raises $31 Million in Series B Funding
    Paragonix Launches Global Registry for Studying Donor Lung Preservation Paragonix Launches Global Registry for Studying Donor Lung Preservation
    FDA Approves Abbott FDA Approves Abbott's Portico with FlexNav TAVR System
    Presidio Medical Names Michael Onuscheck as CEO Presidio Medical Names Michael Onuscheck as CEO

    Related Literature / Brochures

    • MEDICAL & BIOTECH MANUFACTURING

      ISO 13485:2016 • FDA Registered

    • Breakthrough Device Designation Granted for New Neuromodulation Platform

      Breakthrough Device Designation Granted for New Neuromodulation Platform

      In a pilot study treating refractory epilepsy with Neuroelectrics’ Starstim platform, patients experienced a 44 percent median reduction in seizure frequency.
      Business Wire 09.22.21

    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Neela Paykel is serving as general counsel and Tom Teisseyre assumes the chief product officer position.
      Business Wire 09.22.21


    • Tubing & Extrusion
      Accu-Tube Appoints Matthew Haddle as CEO

      Accu-Tube Appoints Matthew Haddle as CEO

      Haddle has a track record of leading organizations through strategic expansions across the medical device, aerospace, and industrial sectors.
      Accu-Tube 09.22.21

    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      The two deals will strengthen Heraeus' healthcare and medtech portfolio.
      Heraeus 09.22.21

    Loading, Please Wait..

    Trending
    • CGM Devices Could Become Main Glucose Monitoring Solution In U.S.
    • Study: Smartphone Therapeutic Helps Improve Fibromyalgia In Patients
    • MO SCI Acquires Assets Of 3M’s Advanced Materials Business
    • Positive Long-Term Prospects For Japanese Diabetes Care Market
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • Freudenberg Medical Adds Silicone Extrusion Capabilities in Massachusetts
    • Positive Long-Term Prospects for Japanese Diabetes Care Market
    • Digital X-Ray is as Effective as Lung Ventilation Perfusion in Detecting CTEPH
    • CIBC Innovation Banking Provides $25M in Debt Financing to Podimetrics
    • Invacare's Interim CEO Permanently Secures Job
    View Breaking News >
    CURRENT ISSUE

    January/February 2023

    • Struggling Suppliers in Electronics Manufacturing Services (EMS)
    • Machining & Laser Processing Have Huge Parts to Play
    • Medtech R&D Teams Must Be Creative & Resilient to Survive
    • Medtronic Neuromodulation President, Nnamdi Njoku, Interview
    • 6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NPA Announces Annual Capitol Hill Advocacy ‘Fly-In’ Day
    GOED Elects New Board Officers for 2023
    Aspire Hires Darrec Jones as VP of Business Development
    Coatings World

    Latest Breaking News From Coatings World

    Caren Hoffmann Appointed Vice President for BASF Mining Solutions
    Microban International Announces Four Senior Hires
    PPG Completes COLORFUL COMMUNITIES Project in Denmark
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Freudenberg Medical Adds Silicone Extrusion Capabilities in Massachusetts
    Positive Long-Term Prospects for Japanese Diabetes Care Market
    Digital X-Ray is as Effective as Lung Ventilation Perfusion in Detecting CTEPH
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb 4Q Results
    Actinium, NCI Partner to Develop Actimab-A in AML
    Astellas Announces New President and CEO and Management Structure
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Old Spice Introduces New Mascot and Launches ‘Smelf-Confidence’ Campaign
    KVD Beauty Launches Good Apple Serum Foundation
    Interpack 2023 to Focus on Sustainability
    Happi

    Latest Breaking News From Happi

    EvaClean Promotes Nicole Slacik to Executive Vice President, Healthcare
    Personal Care Brand Odele Expands into Ulta Beauty
    Clorox’s Eric Reynolds Elected Chair of American Cleaning Institute’s Board of Directors
    Ink World

    Latest Breaking News From Ink World

    Mexar Limited Awarded OEKO-TEX ECO PASSPORT Certification
    Graphic Packaging Named to Fortune's List of World's Most Admired Companies
    CDP Awards Amcor an A- for Ongoing Work on Climate Change Disclosure
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Fujifilm expands RxD inkjet pigment dispersions color range
    Anderson & Vreeland acquires flexo consumable assets from Grimco
    Hamillroad Software's Bellissima DMS honored in Brazil
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Avgol to Showcase Algaeing Colorants and Fibers at Filtech
    Uster to Host Webinar on Zero-Level Contamination Control
    Typar Expands Drainable Wrap Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Steady Growth Forecast for Global Orthobiologics Market
    ODT's Most-Read Stories This Week—Feb. 4
    Toetal Solutions Secures $1.8 Million in New Financing
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Exceeds 4Q 2022 Expectations
    Emerson Launches Ovation Green Software Portfolio
    Graphene Flagship Researchers Examine Applications for Space

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login